No matter what they churn out at the end of the line, manufacturers are always searching for ways to lower costs and accelerate production without sacrificing quality. It all comes down to automation ...

There is considerable excitement surrounding the treatment potential of T cell immunotherapies. Amongst these, CAR-T cells have demonstrated impressive therapeutic efficacy in a subset of ...

Discover the groundbreaking manufacturing process behind Tesla's success in this in-depth look at their factory operations. The video explores how Tesla's Giga Press machines deliver unprecedented ...

As part of the EU-funded Clean Sky 2/Clean Aviation project “Large Passenger Aircraft” (“LPA”), the Fraunhofer-Gesellschaft in Stade, Germany, together with international project partners, has joined ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, ...

Modern production lines require seamless automation integration, traceable data, uncompromised measurement integrity, and ...

The advanced air mobility (AAM) market is gaining traction to transform the transportation of goods and people. While OEMs have focused on design and certification, supply chains have been left to ...

A closer look at how robotics is reshaping pharmaceutical manufacturing, from improving quality and compliance to enabling more scalable production, and where the technology is headed next.

Those who have always dreamed of working with robots, enjoy computers, or simply want to further their career possibilities are training to meet Birmingham's automated manufacturing needs.Automated ...

Patented multi-blade technology and parallel high-speed transport systems ensure precision, reliability and high-volume razor ...

SHENZHEN, GUANGDONG, CHINA, March 17, 2026 /EINPresswire.com/ -- In the complex architecture of modern industrial ...

Collaboration with intent to validate Cellares’ Cell Shuttle platform for manufacturing of CABA-201, Cabaletta Bio’s fully human CD19-CAR T product candidate, which is being evaluated in parallel ...